AAKASHI PATEL: Open Payments
NPI 1184069973 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 56 payments from 13 companies in 2025. Trend: 2023 $204 · 2024 $731 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $296 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $87 |
| Madrigal Pharmaceuticals | 2 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| VIVUS LLC | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: XIFAXAN, ENTYVIO, RINVOQ, LifeVest, REZDIFFRA, OMVOH, LINZESS, MAVYRET.
Industry payments across GA — which companies pay providers there.
